News from the healthcare data industry
une 26, 2024 MONTREAL – The McGill University Health Centre (MUHC) is proud to announce the launching of the ADAMS Centre, a facility designated to maximize the potential and facilitate the integration of the new MDClone technology within the hospital’s various departments. This data analysis technology will serve as the…
June 24, 2024 09:55 AM Eastern Daylight Time PALO ALTO, Calif.–(BUSINESS WIRE)–Atropos Health today announced the expansion of the Atropos Evidence Network to include two new partners, adding to the growing number of datasets and use cases for the Atropos Evidence Network including oncology and international. The company additionally announced…
PHILADELPHIA, June 24, 2024 /PRNewswire/ — HealthVerity, the leader in synchronizing transformational technologies and real-world data (RWD) to advance the science, today announced the launch of HealthVerity taXonomy – the nation’s most comprehensive, highly-curated and research-ready closed claims dataset for pharmaceutical safety, real-world evidence, and health economics and outcomes research organizations. This next-generation data solution…
BARCELONA, Spain, June 24, 2024 /PRNewswire/ — Aetion®, the global leader in real-world evidence (RWE) technology and analytics, announced today the creation of an RWE technology hub in Barcelona, Spain, to convene the most capable group of dedicated RWE technologists in the industry. Aetion also announced the appointment of Ken Watson as Chief Technology Officer…
Reacting to new regulatory draft guidance on observational studies, stakeholders asked the US Food and Drug Administration (FDA) to flesh out its advice with examples and to ensure consistency with other real-world evidence (RWE) reports. FDA outlined its thoughts on protocol design and approaches as “considerations” for non-interventional studies of…
BELLEVUE, Wash., June 18, 2024 (GLOBE NEWSWIRE) — Today, Truveta announced regulatory and audit capabilities to support its customers for real-world evidence (RWE) submissions to the Food and Drug Administration (FDA) and other global regulatory authority decisions. These regulatory grade capabilities advance Truveta’s safety, health economics and outcomes research (HEOR),…
Norstella, one of the largest global pharma intelligence solution providers, today announced a strategic partnership with Atropos Health, the pioneer in translating real-world clinical data into high-quality personalized real-world evidence for care. BOSTON, June 17, 2024 /PRNewswire-PRWeb/ — Norstella, one of the largest global pharma intelligence solution providers, today announced a strategic…
Improving life sciences research, clinical studies and post-market surveillance powered by data and AI NEWTOWN, Pa., June 13, 2024 /PRNewswire/ — EPAM Systems, Inc. (NYSE: EPAM), a leading digital transformation services and product engineering company, today announced its acquisition of Odysseus Data Services, Inc., a top health data analytics company. Odysseus will expand EPAM’s ability to transform…
Tempus AI, Inc. (“Tempus”) today announced the pricing of its initial public offering of 11,100,000 shares of its Class A common stock at a public offering price of $37.00 per share. All of the shares of Class A common stock are being offered by Tempus. The gross proceeds to Tempus…
SAN FRANCISCO, June 12, 2024 (GLOBE NEWSWIRE) — Verana Health®, a digital health company dedicated to revolutionizing patient care and clinical research through real-world data (RWD), announces new functionality within its VeraSite and Verana Trial Connect (VTC) software as a service applications, which will further drive optimization for trial sponsors and practice sites. As clinical…